Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia

We have previously reported on the efficacy and tolerability of hyper-CVAD regimen (cyclophosphamide, vincristine, Adriamycin, and dexamethasone) and imatinib followed by imatinib-based consolidation/maintenance therapy in 20 patients with newly diagnosed Philadelphia-positive acute lymphoblastic le...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Daver, Naval, Thomas, Deborah, Ravandi, Farhad, Cortes, Jorge, Garris, Rebecca, Jabbour, Elias, Garcia-Manero, Guillermo, Borthakur, Gautam, Kadia, Tapan, Rytting, Michael, Konopleva, Marina, Kantarjian, Hagop, O’Brien, Susan
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4420214/
https://ncbi.nlm.nih.gov/pubmed/25682595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.118588
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados